The Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer

Faris Abushamma1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine;2 Department of Urology, An-Najah National University Hospital, Nablus, 44839, Palestine;3 Bristol Urological Institute, North Bristol NHS Trust, Bristol, UKCorrespondence[email protected]

Zain Khayyat1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine

Aya Soroghle1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine

Sa’ed H Zyoud4 Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, an-Najah National University, Nablus, 44839, Palestine;5 Clinical Research Center, an-Najah National University Hospital, Nablus, 44839, Palestine

Ahmad Jaradat1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine;2 Department of Urology, An-Najah National University Hospital, Nablus, 44839, Palestine

https://orcid.org/0000-0002-6537-2943

Maha Akkawi1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine;6 Department of Pathology, An-Najah National University Hospital, Nablus, 44839, Palestine

Hanood Aburass1 Department of Medicine, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine;6 Department of Pathology, An-Najah National University Hospital, Nablus, 44839, Palestine

https://orcid.org/0000-0003-1949-4883

Iyad K K Qaddumi7 Department of Urology, Rafedia General Hospital, Nablus, 44839, Palestine

Razan Odeh8 Department of Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine

Husam Salameh8 Department of Oncology, An-Najah National University Hospital, Nablus, 44839, Palestine

Salah Albuheissi3 Bristol Urological Institute, North Bristol NHS Trust, Bristol, UK

show all

The Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date